• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ICU MEDICAL, INC. SPIROS CLOSED SYSTEM TRANSFER DEVICE; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ICU MEDICAL, INC. SPIROS CLOSED SYSTEM TRANSFER DEVICE; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Device Problem Use of Device Problem (1670)
Patient Problem Insufficient Information (4580)
Event Description
Small volume iv push methotrexate is administered to post bmt patients in a syringe with a spiros cstd (closed system transfer device).The spiros cstd is not used for compounding and is not primed with drug.The prime volume is 0.1 ml.There is concern that a significant portion of the dose is not injected with the use of this cstd.There is 0.1 ml left behind in the dead space of the spiros closed system transfer device.This dead space volume was not appreciated during 1 year of use and resulted in underdosing of methotrexate at our facility.Pump failure/malfunction inappropriate/inaccurate measuring device improperly used (i.E., pump, device) dispensing device involved.Severity: error resulted in initial or prolonged hospitalization; temporary patient harm.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPIROS CLOSED SYSTEM TRANSFER DEVICE
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
ICU MEDICAL, INC.
MDR Report Key12787904
MDR Text Key280819760
Report NumberMW5105251
Device Sequence Number1
Product Code FPA
Combination Product (y/n)Y
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 02/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/09/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Patient Sequence Number1
-
-